HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Patrício Soares-da-Silva Selected Research

nebicapone

1/2012Bioanalytical chromatographic methods for the determination of catechol-O-methyltransferase inhibitors in rodents and human samples: a review.
12/2010A double-blind, randomized, placebo and active-controlled study of nebicapone for the treatment of motor fluctuations in Parkinson's disease.
1/2008Effects of nebicapone on levodopa pharmacokinetics, catechol-O-methyltransferase activity, and motor fluctuations in patients with Parkinson disease.
11/2003Pharmacokinetic-pharmacodynamic interaction between BIA 3-202, a novel COMT inhibitor, and levodopa/benserazide.
6/2003Catechol-O-methyltransferase inhibition in erythrocytes and liver by BIA 3-202 (1-[3,4-dibydroxy-5-nitrophenyl]-2-phenyl-ethanone).

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Patrício Soares-da-Silva Research Topics

Disease

34Parkinson Disease (Parkinson's Disease)
09/2022 - 06/2003
18Seizures (Absence Seizure)
10/2021 - 12/2004
13Hypertension (High Blood Pressure)
07/2021 - 01/2002
12Epilepsy (Aura)
01/2021 - 12/2004
6Heart Failure
01/2019 - 03/2002
5Dyskinesias (Dyskinesia)
01/2020 - 01/2007
4Partial Epilepsies (Epilepsy, Partial)
10/2020 - 03/2007
4Body Weight (Weight, Body)
10/2019 - 10/2015
3Nervous System Diseases (Neurological Disorders)
10/2020 - 01/2007
3Bipolar Disorder (Manic Depressive Psychosis)
03/2015 - 01/2007
3Essential Hypertension
10/2014 - 01/2004
2Pain (Aches)
03/2022 - 10/2018
2Cardiomegaly (Heart Hypertrophy)
07/2021 - 01/2019
2Unconsciousness (Loss of Consciousness)
05/2020 - 10/2019
2Hypersensitivity (Allergy)
05/2020 - 05/2008
2Neuroblastoma
03/2019 - 02/2015
2Inflammation (Inflammations)
01/2019 - 04/2016
2Sleep Initiation and Maintenance Disorders (Insomnia)
01/2019 - 01/2016
2Constipation
01/2019 - 01/2016
2Breast Neoplasms (Breast Cancer)
05/2018 - 12/2017
2Temporal Lobe Epilepsy
01/2018 - 02/2014
2Diarrhea
10/2017 - 01/2016
2Inflammatory Bowel Diseases (Inflammatory Bowel Disease)
10/2017 - 10/2015
1Dizziness (Lightheadedness)
10/2021
1Tremor (Tremors)
02/2021
1Stroke (Strokes)
01/2020
1Frailty
10/2019
1Adenocarcinoma
03/2019
1Metabolic Syndrome (Dysmetabolic Syndrome X)
01/2019
1Cardiovascular Diseases (Cardiovascular Disease)
01/2019
1Pulmonary Arterial Hypertension
05/2018
1Drug-Related Side Effects and Adverse Reactions
12/2017
1Hyponatremia
12/2017
1Porcine Reproductive and Respiratory Syndrome (PRRS)
10/2017
1Mania (Manias)
03/2015
1Tachycardia (Tachyarrhythmias)
01/2015
1Peripheral Nervous System Diseases (PNS Diseases)
11/2014
1Schizophrenia (Dementia Praecox)
11/2014

Drug/Important Bio-Agent (IBA)

27Levodopa (L Dopa)FDA LinkGeneric
09/2022 - 06/2003
23eslicarbazepine acetateIBA
10/2021 - 08/2004
21opicaponeIBA
09/2022 - 01/2012
14Catechol O-Methyltransferase (Methyltransferase, Catechol)IBA
02/2021 - 11/2003
10Dopamine (Intropin)FDA LinkGeneric
10/2020 - 01/2002
10Anticonvulsants (Antiepileptic Drugs)IBA
12/2017 - 12/2004
8Carbamazepine (Tegretol)FDA LinkGeneric
10/2020 - 12/2004
7SodiumIBA
10/2017 - 03/2002
5nebicaponeIBA
01/2012 - 06/2003
4Pharmaceutical PreparationsIBA
10/2021 - 01/2010
4SaltsIBA
07/2021 - 01/2004
4eslicarbazepineIBA
03/2015 - 02/2014
3zamicastatIBA
10/2019 - 05/2018
3entacapone (Comtan)FDA Link
01/2016 - 01/2008
3Voltage-Gated Sodium ChannelsIBA
03/2015 - 01/2007
3Amino Acid Transport Systems (Amino Acid Transporter)IBA
08/2013 - 12/2007
2BenserazideIBA
02/2021 - 12/2010
2Propofol (Diprivan)FDA LinkGeneric
05/2020 - 10/2019
2Tolcapone (Tasmar)FDA Link
03/2019 - 01/2016
2Norepinephrine (Noradrenaline)FDA LinkGeneric
01/2019 - 05/2018
2Member 1 Subfamily B ATP Binding Cassette TransporterIBA
05/2018 - 12/2017
2Proteins (Proteins, Gene)FDA Link
05/2018 - 12/2017
2Mixed Function Oxygenases (Monooxygenases)IBA
05/2018 - 01/2015
2etamicastatIBA
05/2018 - 01/2015
2Sodium Channels (Sodium Channel)IBA
01/2018 - 02/2015
210,11- dihydro- 10- hydroxy- 5H- dibenz(b,f)azepine- 5- carboxamideIBA
01/2018 - 02/2014
2Pattern Recognition ReceptorsIBA
10/2017 - 10/2015
2Adenosine Triphosphatases (ATPase)IBA
01/2016 - 12/2007
2Sodium-Hydrogen ExchangersIBA
01/2016 - 12/2007
2Biological ProductsIBA
11/2014 - 12/2004
2Oxcarbazepine (Trileptal)FDA LinkGeneric
08/2010 - 12/2004
1Dopa DecarboxylaseIBA
03/2022
1Protein Isoforms (Isoforms)IBA
07/2021
13-methoxytyrosineIBA
02/2021
11- Methyl- 4- phenyl- 1,2,3,6- tetrahydropyridine (MPTP)IBA
02/2021
1nitrocatecholIBA
02/2021
1BIA 10-2474IBA
01/2020
1Biomarkers (Surrogate Marker)IBA
01/2019
1fatty-acid amide hydrolase (fatty acid amide hydrolase)IBA
10/2018
1nepicastatIBA
05/2018
1Pilocarpine (Ocusert)FDA LinkGeneric
01/2018
1LacosamideFDA Link
01/2018
1Catechol O-Methyltransferase InhibitorsIBA
12/2017
1FlagellinIBA
10/2017
1loxoribineIBA
10/2017
1LigandsIBA
10/2017
1Aromatic-L-Amino-Acid DecarboxylasesIBA
01/2017
1Neurotransmitter Agents (Neurotransmitter)IBA
04/2016
1ElectrolytesIBA
04/2016
1AminesIBA
04/2016
1PotassiumIBA
01/2016
1gamma-Aminobutyric Acid (GABA)IBA
10/2015
1Ethosuximide (Zarontin)FDA LinkGeneric
10/2015
1Antihypertensive Agents (Antihypertensives)IBA
01/2015
1Amino AcidsFDA Link
12/2014
1latrunculin A (LAT-A)IBA
12/2014

Therapy/Procedure

29Therapeutics
03/2022 - 12/2004
1Off-Label Use
10/2021
1Catheters
09/2015
1Oral Administration
12/2014
1Electrodes (Electrode)
02/2014
1Drug Therapy (Chemotherapy)
04/2013